Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nasopharyngeal Carcinoma 20 Carcinoma, Non-Small-Cell Lung 18 Esophageal Squamous Cell Carcinoma 15 Breast Neoplasms 14 Triple Negative Breast Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 11 Carcinoma, Hepatocellular 11 Stomach Neoplasms 8 Small Cell Lung Carcinoma 8 Uterine Cervical Neoplasms 6 Recurrence 6 Head and Neck Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Transitional Cell 5 Carcinoma, Renal Cell 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Rectal Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Locally Advanced Rectal Cancer 3 Liver Neoplasms 3 Turcot syndrome 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Neoplasms 2

Interventions

Specimen Handling 2 Nivolumab 2 toripalimab 1 talimogene laherparepvec 1 bicalutamide 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Fluorescein 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Paget Disease, Extramammary × toripalimab × Clear all

NCT06791070 2025-01-24

RC48&J for EPD

Fujian Medical University Union Hospital

Phase 2 Recruiting

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡